Incretin-based therapies and craving: a clinical signal pointing to reward reprogramming

Matteo Monami, Edoardo Mannucci, Ricardo Cohen

Open source

DOI
10.1016/j.numecd.2026.104818
Published
2026-06
Container
Nutrition, Metabolism and Cardiovascular Diseases
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.numecd.2026.104818,
  title = {Incretin-based therapies and craving: a clinical signal pointing to reward reprogramming},
  author = {Matteo Monami and Edoardo Mannucci and Ricardo Cohen},
  year = {2026},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  doi = {10.1016/j.numecd.2026.104818},
  url = {https://doi.org/10.1016/j.numecd.2026.104818}
}

RIS

TY  - JOUR
TI  - Incretin-based therapies and craving: a clinical signal pointing to reward reprogramming
AU  - Matteo Monami
AU  - Edoardo Mannucci
AU  - Ricardo Cohen
PY  - 2026
JO  - Nutrition, Metabolism and Cardiovascular Diseases
DO  - 10.1016/j.numecd.2026.104818
UR  - https://doi.org/10.1016/j.numecd.2026.104818
ER  - 

APA

Monami, M., Mannucci, E., & Cohen, R. (2026). Incretin-based therapies and craving: a clinical signal pointing to reward reprogramming. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2026.104818

Source records